109 related articles for article (PubMed ID: 2456347)
21. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
Colombo MP; Pierotti MA; Ballinari D; Parmiani G
Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
[TBL] [Abstract][Full Text] [Related]
22. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
Afifi MS; Kumar V; Bennett M
J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
[TBL] [Abstract][Full Text] [Related]
24. Comparison between murine natural antibodies and natural killer cells: recognition of separate target structures as revealed by differential in vitro expression and dependence on glycosylation.
Grönberg A; Eriksson E; Sinangil F; Rönnholm M; Feizi T; Minden P; Kiessling R
J Natl Cancer Inst; 1985 Jan; 74(1):67-75. PubMed ID: 2982055
[TBL] [Abstract][Full Text] [Related]
25. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
26. T cell allotypic determinants encoded by genes linked to the immunoglobulin heavy chain locus. I. Establishment of monoclonal antibodies against allotypic determinants.
Aihara Y; Tadokoro I; Katoh K; Minami M; Okuda K
J Immunol; 1983 Jun; 130(6):2920-5. PubMed ID: 6406598
[TBL] [Abstract][Full Text] [Related]
27. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
28. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
Smith PM; Rich RF; Green WR
Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
[TBL] [Abstract][Full Text] [Related]
29. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
30. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
31. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
32. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
33. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
34. Murine NK cell allospecificity-1 is defined by inhibitory ligands.
Zheng WP; Kiura K; Milisauskas VK; DeNardin E; Nakamura I
J Immunol; 1996 Jun; 156(12):4651-5. PubMed ID: 8648108
[TBL] [Abstract][Full Text] [Related]
35. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
Drizlikh G; Schmidt-Sole J; Yankelevich B
J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated cytotoxicity against allogeneic mutant H-2 antigens: restricted and nonrestricted responses.
Nakamura I
J Immunol; 1984 Jun; 132(6):2742-8. PubMed ID: 6202759
[TBL] [Abstract][Full Text] [Related]
38. Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells.
Carlow DA; Payne U; Hozumi N; Roder JC; Czitrom AA
Eur J Immunol; 1990 Apr; 20(4):841-6. PubMed ID: 2347364
[TBL] [Abstract][Full Text] [Related]
39. Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression.
Kaminsky SG; Yoshida MA; Milisauskas VK; Nakamura I
Immunogenetics; 1992; 35(2):117-25. PubMed ID: 1735558
[TBL] [Abstract][Full Text] [Related]
40. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
